09:30 Registration and welcome coffee

Start-ups and funding

Moderator: Dr. Asta Partanen, nova-Institut GmbH, DE 


Michael Carus, nova-Institut GmbH, DE Basic data on European Bio-based Economy and smart CAPEX calculation for early stage projects


Jim Philp, OECD, FR Public investments and funding for start-ups


Dr. Carl Henning Reschke, KPMG AG, DE Market entry strategies – reducing complexity
11:00 – 11:30 Coffee break and exhibition on Start-ups, Funding and Industry – meet the Start-ups

Start-ups selected by the nova-Institute

Moderator: Michael Carus, nova-Institut GmbH, DE
11:30 Dawid Wróblewski, BIOTREM, PL BIOTREM: processing wheat bran into packaging products - Abstract here


Dr. Lisa Dyson, Kiverdi, Inc., US Using CO2 & CO to make Oleochemicals and Specialty Oils - Abstract here


Federico Maria Grati, Mycoplast S.n.c., IT MOGU - Biomaterials from mycelium and agro-insdustrial wastes


Daniel Pohludka, Nafigate Corporation, A.S., CZ Hydal Biotechnology - Game Changing Innovation - Abstract here


Andres Pajuste, NordBioChem OÜ, EE Cost effective C3-fermentation chemistry - the NordBioChem's way out of Fossils - Abstract here


Max Beaumont, Skytree, NL Carbon Dioxide from the air? Skytree's solution to providing a convenient and reliable source of recycled CO2 as feedstock for biomass and fuel production - Abstract here
13:00 – 14:00 Lunch break and exhibition on Start-ups, Funding and Industry – meet the Start-ups

Start-ups from CLIB2021

Moderator: Dr. Tatjana Schwabe, CLIB2021, DE


Dr. Wilfried Schwab4GENE, DE Flavor-on-Demand - Abstract here


Dr. Martin Krehenbrink, Cysal GmbH, DE Dipeptides: the future of amino acids - Abstract here
14:30 Gratian Permien, GLYCONIC, DE GLYCONICation of Flavonoids - Abstract here

Start-ups from IBB Netzwerk

Moderator: Prof. Dr. Haralabos Zorbas, IBB Netzwerk, DE
14:45 André Pick, CASCAT GmbH, DE Novel process strategies by use of (chemo)-enzymatic cascade reactions - Abstract here


Dr. Doris Hafenbradl, Electrochaea GmbH, DE Power-To-Gas – from the laboratory to industrial scale - Abstract here
15:15 – 16:30 Coffee break and exhibition on Start-ups, Funding and Industry – meet the Start-ups

Start-ups and funding

Moderator: Tobias Kirchhoff, BCNP Consultants GmbH, DE


Benno Weißner, ZENIT GmbH, Enterprise Europe Network NRW, DE Support by EU and the Enterprise Europe Network for Start-ups - Abstract here


Frank Goebel, B.R.A.I.N. Capital GmbH, DE B.R.A.I.N. - From start-up to public listing - Abstract here


Anindya Mukherjee, i2i - inventions to innovation, DE/US Start-ups - What you need to succeed! - Abstract here
17:30 – 18:00 Panel discussion with Michael Carus, Dr. Carl Henning Reschke, Frank Goebel, Anindya Mukherjee, Jim Philp and Benno Weißner (Moderation: Prof. Dr. Haralabos Zorbas, IBB Netzwerk, DE)
18:00 Coming together

Start-ups selected for the Bio-based Start-up Day!

Dr. Wilfried Schwab, 4GENE (DE) 4GENE develops and produces natural, biotechnologically engineered, activable flavour and fragrance precursors. Products are marketed as FLAVOR-ON-DEMAND to flavour and fragrance customers worldwide.

Malgorzata Then, BIOTREM (PL) BIOTREM uses an organic by-product of milling (wheat husks) to produce tableware that is fully natural and fully compostable. The production process is very clean. Only husks, steam, pressure and heat are needed.

André Pick, CASCAT GmbH (DE) The expertise of CASCAT is to combine the best of two worlds - synthetic biotechnology and classical chemical catalysis - to realize novel process routes. Using this approach, we realize synthetic cascades towards chemical building blocks, fine chemicals as well as pharmaceutical molecules.

Dr. Martin Krehenbrink, Cysal GmbH (DE) Cysal is using microbial metabolic diversity for the development of novel fermentation technologies and products. The current focus is the biotechnological production of dipeptides at an industrial scale and the development of novel applications based on these dipeptides.

Dr. Doris Hafenbradl, Electrochaea GmbH (DE) Electrochaea is developing a disruptive grid-scale energy storage technology. Our power-to-gas (P2G) process converts CO2 and low-cost or stranded electricity into pipeline-grade methane for direct injection into the existing natural gas grid.

Gratian Permien, GLYCONIC (DE) GLYCONIC is a developer of glycoactivated polyphenols. With its state-of-the-art technology GLYCONIC is the preferred partner in cosmetic, pharmaceutical and food industry when it comes to adapting the effectiveness, stability, solubility and bioavailability of polyphenol derivates.

Dr. Lisa Dyson, Kiverdi, Inc. (US) Kiverdi makes high-value oils and chemicals for a variety of product applications such as detergents, biomaterials and fuel additives. Kiverdi’s chemicals are sustainably produced from waste carbon and decoupled from the price fluctuations, supply chain disruptions, and geopolitics associated with commodities.

Federico Maria Grati, Mycoplast S.n.c. (IT) MOGU is a start-up initiative created in January 2015 by Mycoplast, aiming to research, develop and commercialise a wide variety of bio-materials produced from mycelium and agro-industrial residues as substrates.

Daniel Pohludka, Nafigate Corporation, A.S. (CZ) Hydal biotechnology - as the first technology in the world - utilizes 100% waste (used cooking oil) for the production of a bio-based polymer, polyhydroxyalkanoate (PHA), on the industrial scale. First pilot line and plant is being built in Suzhou in China.

Andres Pajuste, NordBioChem OÜ (EE) NordBioChem has developed a whole technological platform starting with the lactic acid fermentation technology suitable for large-scale production and has combined it with new solutions in catalytical mechanisms and chemical derivatisation technologies.

Max Beaumont, Skytree (NL) Based on space technology, Skytree has developed a patented process which re-captures CO2 directly from the ambient air. This allows providing or subtracting carbon-neutral CO2 on-site, anytime, anywhere. This CO2 can in turn be used for such applications as growing plants, ventilation and water treatment.

Advisory Board

Dr. Wolfgang Baltus, PRECISE Corporation (Thailand)
Christiaan Bolck, Wageningen UR (The Netherlands)
Prof. Dr. Ludo Diels, Vito (Belgium)
Prof. Dr. Jörg Müssig, Hochschule Bremen (Germany)
Jan Ravenstijn, Jan Ravenstijn Consulting (The Netherlands)
Dr. Thomas Schwarz, CLIB2021 (Germany)
Prof. Dr. Haralabos Zorbas, IBB Netzwerk (Germany)